Dermatitis, Eczematous Completed Phase 4 Trials for Desonide (DB01260)

Also known as: Eczema / Eczema NOS / Eczematous rash / Dermatitis eczematoid / Eczematous dermatitis

IndicationStatusPhase
DBCOND0057011 (Dermatitis, Eczematous)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02732314Efficacy and Tolerability of New Topical Formulations in Subjects With Atopic DermatitisTreatment